MedTrace Logo

NIRS Monitoring to Detect AKI in Preterm Infants

NCT03384173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2022-11-29

Study results available
· View outcomes & findings →

Summary

This study will examine the relationship of oxygen levels, using Near-infrared spectroscopy (NIRS) monitoring, and kidney injury in infants born prematurely. NIRS is a skin sensor which detects the amount of oxygen going to different organs, most often used to monitor the brain and kidney.

Conditions

Interventions

DEVICE

Near Infrared Spectroscopy

Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Matthew W Harer, MD · University of Wisconsin, Madison

Eligibility

Min Age
1 Minute
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2019-12-31
Completion
2019-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03384173 on ClinicalTrials.gov